I visited with Dr. Daniel Lenihan and spoke with him about cardio-oncology and some of the common issues and concerns that arise. Cardio-oncology is a very broad field and revolves around managing cardiovascular toxicities associated with cancer therapies. We discuss the classic example of anthracycline toxicity and touch on some of the newer therapies (immune checkpoint inhibitors).
Preparing the Cardiovascular Workforce to Care for Oncology Patients
Dr. Caroline Kahle discussed a few cases I’ve encountered during medical training. How do we perceive end of life care or code situations in complex situations? We talk about non-beneficial medical care, physician communication and some pearls Dr. Kahle has learned in her experiences in medical ethics.
I met with Dr. Thomas Maddox, the director of the Health Systems Innovation Lab at BJC/WashU, to discuss an upcoming pilot program to remotely monitor patients with heart failure. The lab has partnered with Myia Labs using technology they have developed to monitor these patients at home. We discuss the ‘ballistocardiograph’ and how they are planning to incorporate it into clinical practice.
